ADARX PHARMACEUTICALS

What this means for you

Not registered yet, but its 11 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99279029

Mark type

Stylized text

Filed

11 Jul 2025

Attorney of record

Kun Wang

Goods and services

• Class 001 — Chemicals: Nucleotides for scientific and research use; nucleotides for use in the manufacture of pharmaceuticals
• Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer
• Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scientific research and development in the field of RNA-based therapeutics; design and testing of RNA agents; bioinformatics and genomic data analysis for therapeutic development

Owner

• ADARX PHARMACEUTICALS, INC., San Diego, CA, US

Prosecution history

• 07 Mar 2026 — LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
• 04 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 04 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 04 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 06 Jan 2026 — LETTER OF PROTEST EVIDENCE FORWARDED
• 06 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 06 Dec 2025 — NON-FINAL ACTION E-MAILED
• 06 Dec 2025 — NON-FINAL ACTION WRITTEN
• 01 Dec 2025 — ASSIGNED TO EXAMINER
• 17 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 03 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 03 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 03 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 03 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 18 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED